Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 5

Research Article

A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks

Table 5

TCM syndrome score.

TimeTreatmentControlStatisticsP value

Day 0Chest pain0.07(Z)0.9444
Chest tightness1.04(Z)0.2998
Shortness of breath-0.53(Z)0.5971
Dark and purple lip-0.02(Z)0.9827
Tongue manifestation-0.63(Z)0.5255
Pulse manifestation-0.32(Z)0.7489
TCM syndrome score-1.28(Z)0.1992
Day 7Chest pain0.25(Z)0.8050
Chest tightness0.43(Z)0.6656
Shortness of breath0.75(Z)0.4534
Dark and purple lip0.84(Z)0.4036
Tongue manifestation0.75(Z)0.4534
Pulse manifestation0.84(Z)0.4036
TCM syndrome score0.49(Z)0.6265
Day 30Chest pain0.04(Z)0.9683
Chest tightness-0.48(Z)0.6277
Shortness of breath6.48(Z)<0.0001
Dark and purple lip4.54(Z)<0.0001
Tongue manifestation7.55(Z)<0.0001
Pulse manifestation5.73(Z)<0.0001
TCM syndrome score7.46(Z)<0.0001
Day 90Chest pain0.23(Z)0.8206
Chest tightness-0.94(Z)0.3447
Shortness of breath6.19(Z)<0.0001
Dark and purple lip0.79(Z)0.4272
Tongue manifestation4.65(Z)<0.0001
Pulse manifestation1.37(Z)0.1695
TCM syndrome score4.13(Z)<0.0001

Note: on day 0, P value indicated comparison between the 2 arms; on days 7, 30, and 90, P value indicated the degree of improvement after treatment. indicated statistically significant difference between pre- and posttreatment.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.